Validity of the neurological examination in diagnosing diabetic peripheral neuropathy

Pediatr Neurol. 2013 Sep;49(3):171-7. doi: 10.1016/j.pediatrneurol.2013.03.014. Epub 2013 Jul 4.

Abstract

The aim of this study was to evaluate the prevalence of diabetic peripheral neuropathy in children and adolescents with type 1 diabetes mellitus and examine whether the neurological examination validly diagnoses diabetic peripheral neuropathy as compared with the gold standard of nerve conduction velocity in these patients. Nerve conduction velocity was measured in an unselected consecutive series of patients aged 8-18 years who had been suffering from type 1 diabetes mellitus for at least 1 year. For the neurological examination, neuropathy disability scores and neuropathy sign scores were used. Of the 39 patients, six (15%) had clinically evident diabetic peripheral neuropathy, whereas nerve conduction velocity testing revealed diabetic peripheral neuropathy in 15 (38%) patients. Sensitivity and specificity of the neurological examination for the diagnosis of diabetic peripheral neuropathy were 40% and 100%, respectively. The corresponding positive and negative predictive values were 100% and 72.7%, respectively. This conclusions from this study are that in children and adolescents with type 1 diabetes mellitus, diabetic peripheral neuropathy is highly prevalent, but in the majority of patients it is subclinical. Sensitivity and negative predictive values of the neurological examination are low. Therefore, routine nerve conduction velocity measurement for the assessment of diabetic peripheral neuropathy appears to be warranted in these patients.

MeSH terms

  • Action Potentials / physiology
  • Adolescent
  • Child
  • Diabetic Neuropathies* / diagnosis
  • Diabetic Neuropathies* / epidemiology
  • Diabetic Neuropathies* / physiopathology
  • Electric Stimulation
  • Female
  • Glycated Hemoglobin / metabolism
  • Humans
  • Male
  • Median Nerve / physiopathology
  • Neural Conduction / physiology*
  • Neurologic Examination / methods*
  • Prevalence
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Severity of Illness Index

Substances

  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human